Bicalutamide
Overview
Bicalutamide is an anti-androgen, used for prostate cancer either alone or as an adjunct to other therapy, according to the clinical circumstances. It inhibits the tumour "flare"which may occur after commencing gonadorelin analogue (e.g diethylstilbestrol) administration.
Categories
- 8 Antineoplastics, immunomodulators and drugs used in palliative care
Primary Characterstics
Indications
Back to top
Pharmacokinetics
Back to top
Contraindications
Back to top
Back to top
Side Effects
Back to top
Dosage
Bicalutamide's dosage details are as follows:
| Dose
|
Single Dose
|
Frequency
|
Route
|
Instructions
|
Adult Dosage
|
| 50 mg | 50 (50) | As recommended. | PO | Daily with orchidectomy or gonadorelin therapy. |
Paedriatic Dosage (20kg)
|
| No data regarding the Paedriatic dosage details of Bicalutamide is available. |
Neonatal Dosage (3kg)
|
| No data regarding the neonatal dosage details of Bicalutamide is available. |
High Risk Groups
Back to top
Warning / Precautions
Back to top
Storage Conditions
Back to top
Interference in Pathology
Back to top
Brands / Trade Names of
Bicalutamide
Back to top
Previous Drug Generic - Next Drug Generic